A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).

CompletedOBSERVATIONAL

Enrollment

330

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

June 9, 2021

Study Completion Date

June 9, 2021

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG

Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

As prescribed by the treating physician

Trial Locations (1)

Many Locations, Multiple Locations